Cargando…
An Analysis Based on Molecular Docking and Molecular Dynamics Simulation Study of Bromelain as Anti-SARS-CoV-2 Variants
The rapid spread of a novel coronavirus known as SARS-CoV-2 has compelled the entire world to seek ways to weaken this virus, prevent its spread and also eliminate it. However, no drug has been approved to treat COVID-19. Furthermore, the receptor-binding domain (RBD) on this viral spike protein, as...
Autores principales: | Tallei, Trina Ekawati, Fatimawali, Yelnetty, Afriza, Idroes, Rinaldi, Kusumawaty, Diah, Emran, Talha Bin, Yesiloglu, Talha Zahid, Sippl, Wolfgang, Mahmud, Shafi, Alqahtani, Taha, Alqahtani, Ali M., Asiri, Saeed, Rahmatullah, Mohammed, Jahan, Rownak, Khan, Md. Arif, Celik, Ismail |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8417730/ https://www.ncbi.nlm.nih.gov/pubmed/34489706 http://dx.doi.org/10.3389/fphar.2021.717757 |
Ejemplares similares
-
Can the SARS-CoV-2 Omicron Variant Confer Natural Immunity against COVID-19?
por: Abas, Abdul Hawil, et al.
Publicado: (2022) -
Fruit Bromelain-Derived Peptide Potentially Restrains the Attachment of SARS-CoV-2 Variants to hACE2: A Pharmacoinformatics Approach
por: Tallei, Trina Ekawati, et al.
Publicado: (2022) -
Interactions of the Receptor Binding Domain of SARS-CoV-2 Variants with hACE2: Insights from Molecular Docking Analysis and Molecular Dynamic Simulation
por: Celik, Ismail, et al.
Publicado: (2021) -
In Silico Evaluation of Iranian Medicinal Plant Phytoconstituents as Inhibitors against Main Protease and the Receptor-Binding Domain of SARS-CoV-2
por: Mousavi, Seyyed Sasan, et al.
Publicado: (2021) -
Potential of Plant Bioactive Compounds as SARS-CoV-2 Main Protease (M(pro)) and Spike (S) Glycoprotein Inhibitors: A Molecular Docking Study
por: Tallei, Trina Ekawati, et al.
Publicado: (2020)